Buscar resultados de ensayos clínicos
Neurofibromatosis 2 - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors Condición: Neurofibromatosis 2 Fecha: 2002-01-30 Intervenciones: Device: Penetrating auditory brainstem implant |
Completed |
Nombre del estudio: Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients Condición: Neurofibromatosis 2 Fecha: 2011-11-30 Intervenciones: Drug: RAD001 10 mg per os / day or 05mg per os / day with 12 month |
Suspended |
Nombre del estudio: PTC299 for Treatment of Neurofibromatosis Type 2 Condición: Neurofibromatosis 2 Fecha: 2009-05-28 Intervenciones: Drug: PTC299 PTC299 will be administered orally at 100 mg/dose twice per day for up to 1 year or until t |
Recruiting |
Nombre del estudio: AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas Condición:
Fecha: 2016-07-07 Intervenciones: Drug: AZD2014 |
Completed |
Nombre del estudio: Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2 Condición: Neurofibromatosis 2 Fecha: 1999-10-18 Intervenciones: Device: Multichannel Auditory Brain Stem Implant |
Recruiting |
Nombre del estudio: Resiliency Training for Patients With NF2 Via Videoconferencing With Skype Condición: Neurofibromatosis 2 Fecha: 2016-06-21 Intervenciones:
|
Completed |
Nombre del estudio: Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 Condición: Neurofibromatosis Type II Fecha: 2011-08-17 Intervenciones: Drug: Everolimus (RAD001) , Afinitor® Everolimus will be provided by Novartis. Everolimus is formul |
Completed |
Nombre del estudio: Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Condición:
Fecha: 2009-09-03 Intervenciones: Drug: Lapatinib Lapatinib is dosed according to age. Lapat |
Active, not recruiting |
Nombre del estudio: Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas Condición:
Intervenciones: Drug: Bevacizumab Treatment will be administered on an out |
Recruiting |
Nombre del estudio: Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Condición:
Fecha: 2016-10-13 Intervenciones: Drug: Icotinib Method of drug administration:oral; Dosage: 125mg/m3/d; Course of treatment: 3 months;Tot |